EyePoint, Inc. (EYPT) stock
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$0.30−0.01 (-3.80%)
Close on Nov 17, 2026Market cap $25.51MP/E –Yield –
EyePoint cash
Cash and short-term investments held at the end of each period.
EyePoint's cash was $180.50M at Jun 30, 2026. For fiscal 2025 it was $306.10M, down 17.5% from the year before. Over ten years it grew 32.6% a year on average. The highest annual figure on record is $370.90M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $306.10M | -17.5% |
| FY2024 | Dec 31, 2024 | $370.90M | +12.1% |
| FY2023 | Dec 31, 2023 | $331.00M | +128.9% |
| FY2022 | Dec 31, 2022 | $144.60M | -31.7% |
| FY2021 | Dec 31, 2021 | $211.60M | +369.6% |
| FY2020 | Dec 31, 2020 | $45.06M | +15.8% |
| FY2018 | Jun 30, 2018 | $38.93M | +128.3% |
| FY2017 | Jun 30, 2017 | $17.05M | -41.5% |
| FY2016 | Jun 30, 2016 | $29.14M | +1.6% |
| FY2015 | Jun 30, 2015 | $28.69M | +56.9% |
| FY2014 | Jun 30, 2014 | $18.28M | +77.9% |
| FY2013 | Jun 30, 2013 | $10.27M | -29.5% |
| FY2012 | Jun 30, 2012 | $14.57M | -39.6% |
| FY2011 | Jun 30, 2011 | $24.13M | +55.5% |
| FY2010 | Jun 30, 2010 | $15.51M | +124.9% |
| FY2009 | Jun 30, 2009 | $6.90M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $180.50M | -29.4% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $222.50M | -30.1% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $306.10M | -17.5% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $204.00M | -19.6% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $255.70M | -8.7% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $318.20M | +6.3% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $370.90M | +12.1% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $253.80M | +86.6% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $280.20M | +96.6% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $299.30M | +144.3% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $331.00M | +128.9% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $136.00M | -13.5% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $142.50M | -16.8% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $122.50M | -35.8% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $144.60M | -31.7% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $157.30M | +31.2% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $171.20M | +34.0% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $190.80M | +37.5% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $211.60M | +369.6% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $119.86M | +315.1% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $127.78M | +456.4% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $138.73M | +424.5% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $45.06M | +15.8% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $28.88M | +75.0% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $22.96M | +76.3% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $26.45M | +120.7% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $38.93M | +128.3% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $16.50M | +7.3% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $13.03M | -25.7% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $11.98M | -46.9% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $17.05M | -41.5% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $15.37M | -53.8% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $17.53M | -16.9% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $22.55M | -6.1% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $29.14M | +1.6% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $33.27M | +5.1% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $21.09M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $24.01M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $28.69M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | $31.66M | – |
See a number that looks wrong?